发明名称 Dry powder formulations and methods for treating pulmonary diseases
摘要 Disclosed are respirable dry powders comprising a respirable dry particle comprising monovalent and/or divalent metal ions, one or more therapeutic agents, and optionally an excipient. The metal ions are preferable magnesium, calcium or sodium. The powders are useful in the manufacture of a medicament for treating or preventing a respiratory disease or inflammation. The mole ratio of divalent to monovalent cation is between 2:1 and 8:1. In particular there is disclosed a composition comprising magnesium lactate, one or more therapeutic agents and leucine. The volume median geometric diameter (VMGD) is 10 microns or less, the dispersibility ratio (1/4 bar) of 2.0 or less as measured by laser diffraction (RODOS/HELOS system), and the tap density of about 0.4 g/cc to about 1.2 g/cc.
申请公布号 NZ703804(A) 申请公布日期 2016.05.27
申请号 NZ20110703804 申请日期 2011.08.26
申请人 PULMATRIX OPERATING COMPANY INC. 发明人 LIPP MICHAEL M.;SUNG JEAN C.;CLARKE ROBERT W.;HAVA DAVID L.
分类号 A61K31/198;A61K9/00;A61K33/06;A61K33/14;A61P11/00;A61P11/10 主分类号 A61K31/198
代理机构 代理人
主权项
地址